Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05732558
Other study ID # ESBB1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 16, 2022
Est. completion date March 8, 2023

Study information

Verified date March 2023
Source R.A.W. - S.R.L.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical study is to evaluate the duration of the procedure, the precision (distance between the needle tip and the centre of the target), and the safety of endosight system in the guidance for bone biopsies.


Description:

In this study results obtained in the prospective group will be compared with those obtained in the retrospective group. Total N° of patients: 16 PROSPECTIVE GROUP (treated WITH the guidance of endosight): N° of patients: 8 RETROSPECTIVE GROUP (treated WITHOUT the guidance of endosight): N° of patients: 8 Main objective of the study: Reduction of execution times by at least 10 minutes; Reduction of the number of CT scans by at least 2 scans. N°of hospitals involved: 2. Duration: maximum 6 months from the date of the first enrollment. No follow-up is expected.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date March 8, 2023
Est. primary completion date March 8, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient with a bone lesion for which a percutaneous biopsy is indicated; - Informed consent signed by the patient for participation in the study. Exclusion Criteria: - Age < 18 years; - Pregnant and lactating women (assessed through auto declaration of the patient)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
8 Patients who were prescribed a CT-guided percutaneous bone biopsy, performed with the aid of endosight navigation system
The study is based on a comparison of the number of CT scans required for needle placement in bone biopsies (trunk area) performed with augmented reality navigation system (endosight) and without.

Locations

Country Name City State
Italy IRCCS Ospedale Galeazzi - Sant'Ambrogio Milano MI

Sponsors (1)

Lead Sponsor Collaborator
R.A.W. - S.R.L.

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Procedure time Change in the total duration of the procedure (calculated from the time of local anesthesia injection to the time of bone sample collection) During bone biopsy procedure (after the bone sample has been collected)
Primary Total number of CT-SCAN Change in overall number of CT scans performed during the procedure (calculated as the total number of CT scans required to reach the target; from the 1° CT-scan (local anesthesia) to the last CT-scan (sample collection from the bone) During bone biopsy procedure (after the bone sample has been collected)
Secondary endosight accuracy Distance between the tip of the needle and the center of the target (from 0mm to 10mm) During bone biopsy procedure (after the bone sample has been collected)
Secondary Total radiation dose Change in the total radiant dose received by the patient (calculated by summing the radiation emitted for each CT-Scan performed from the anesthesia-point to the collection-point) During bone biopsy procedure (after the bone sample has been collected)
Secondary Operator satisfaction satisfaction level of the operator (from 0 to 5 - 1: poor satisfaction, 5: high satisfaction) During bone biopsy procedure (after the bone sample has been collected)
Secondary Side effects Total number of major+minor side effects, reported during the procedure During bone biopsy procedure (after the bone sample has been collected)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05515068 - Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
Completed NCT02862288 - Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. Phase 1/Phase 2
Withdrawn NCT01679691 - The Epidural Anesthesia on the Intra-operative and Post-operative Amount of Bleeding Post Lower Limb Salvage Surgery N/A
Recruiting NCT04178044 - Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection Phase 1
Completed NCT03389724 - Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia Phase 3
Completed NCT05075889 - Utility of ICG in Benign Bone Tumors Early Phase 1
Completed NCT04755140 - Endoprosthesis Metal Toxicity Study
Not yet recruiting NCT03427632 - Role of Percutaneous Vertebroplasty in Treatment of Vertebral Tumors N/A
Completed NCT04798326 - Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults Phase 1
Recruiting NCT06459141 - The Effect of Hemodilution on Intraoperative Allogeneic Transfusion (HEAL) N/A
Not yet recruiting NCT06453642 - Evaluation of a Simple-Prep Controlled Embolic N/A
Active, not recruiting NCT04104750 - The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,
Completed NCT00598741 - Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors N/A
Completed NCT02398058 - Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) Phase 1
Recruiting NCT06171282 - A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors Early Phase 1
Not yet recruiting NCT06376682 - EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy N/A
Enrolling by invitation NCT05772312 - Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery
Recruiting NCT06455722 - [68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors Early Phase 1
Recruiting NCT05779670 - Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
Recruiting NCT06180525 - Radiological Evaluation of 3D Printed Porous Collars in Hip and Knee Resection Prostheses: Pilot Study.